BGI to Offer Noninvasive Trisomy Test in Czech, Slovak Republics | GenomeWeb

NEW YORK (GenomeWeb News) – BGI has partnered with GENNET, a Prague-based center for genetics, fetal medicine, and assisted reproduction, to offer its non-invasive fetal trisomy test, NIFTY, in the Czech and Slovak Republics.

The NIFTY test uses next-generation sequencing to analyze maternal plasma for fetal aneuploidies including trisomy 21, trisomy 13, and trisomy 18, which cause Down syndrome, Patau syndrome, and Edwards syndrome, respectively.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Feb
25
Sponsored by
Omicia

This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions. 

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies. 

Mar
17
Sponsored by
Qiagen

This webinar will discuss Qiagen's approach to address two challenges facing NGS in the clinical research setting: lack of seamless workflow for routine clinical research use and truly relevant content to guide clinical research activities.